MiMedx Group, Inc.
MDXG
$4.36
-$0.05-1.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.11% | 35.30% | 13.07% | 4.13% | 7.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.11% | 35.30% | 13.07% | 4.13% | 7.00% |
| Cost of Revenue | 12.69% | 22.17% | 25.76% | 27.50% | 22.16% |
| Gross Profit | 30.32% | 38.22% | 10.47% | -0.10% | 4.12% |
| SG&A Expenses | 19.62% | 27.39% | 40.37% | 8.17% | 11.32% |
| Depreciation & Amortization | -33.16% | -41.67% | -47.37% | -47.62% | 0.52% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.66% | 26.09% | 35.26% | 11.89% | 14.60% |
| Operating Income | 89.07% | 93.63% | -47.25% | -37.74% | -28.03% |
| Income Before Tax | 93.75% | 100.10% | -43.97% | -24.52% | -19.15% |
| Income Tax Expenses | 73.29% | 72.30% | -39.43% | -32.33% | 110.20% |
| Earnings from Continuing Operations | 104.24% | 112.59% | -45.42% | -22.49% | -85.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -100.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.24% | 106.89% | -45.43% | -24.17% | -86.09% |
| EBIT | 89.07% | 93.63% | -47.25% | -37.74% | -28.03% |
| EBITDA | 71.86% | 117.84% | -36.88% | -18.14% | -13.23% |
| EPS Basic | 102.77% | 105.26% | -45.57% | -24.64% | -87.15% |
| Normalized Basic EPS | 90.87% | 93.78% | -44.16% | -33.52% | -33.79% |
| EPS Diluted | 99.40% | 113.59% | -49.83% | -22.19% | -86.13% |
| Normalized Diluted EPS | 90.95% | 93.12% | -44.15% | -32.84% | -19.08% |
| Average Basic Shares Outstanding | 0.74% | 0.73% | 0.30% | 0.59% | 23.16% |
| Average Diluted Shares Outstanding | 0.63% | 0.90% | 0.28% | -0.23% | 0.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |